OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
1
Result
Show all
Save search
Copy query
Show results for
Proteomics
(1)
Organisms
Andropogon gerardi
(1)
Bacteria
(1)
Canis lupus familiaris
(1)
Clostridium perfringens
(1)
Cnidaria
(1)
Cricetulus griseus
(1)
Eukaryota
(1)
Fasciola
(1)
Hepatitis B virus
(1)
Human betaherpesvirus 5
(1)
Madurella mycetomatis
(1)
Mesocricetus auratus
(1)
Miscanthus x giganteus
(1)
Mus musculus
(1)
Mycobacterium tuberculosis
(1)
Orthoflavivirus
(1)
Panicum virgatum
(1)
Platyhelminthes
(1)
Pseudomonas aeruginosa AES-1R
(1)
Rattus norvegicus
(1)
Saccharomyces cerevisiae
(1)
Schizosaccharomyces pombe
(1)
Severe acute respiratory syndrome coronavirus 2
(1)
Shigella
(1)
Sorghastrum nutans
(1)
Streptococcus dysgalactiae subsp. equisimilis SK1249
(1)
Streptococcus pneumoniae
(1)
Streptomyces coelicolor A3(2)
(1)
Toxoplasma gondii
(1)
Tripsacum dactyloides
(1)
Repository
pride
(1)
Tissue
Cell culture
(1)
Permanent cell line cell
(1)
Disease
Cervix carcinoma
(1)
Technology Type
Gel-based experiment
(1)
Mass Spectrometry
(1)
Publication Date
2022
(1)
Lab affiliation
Department of Chemistry, University of Oslo, Oslo, Norway
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
SILAC-based quantitative proteomics of cancer cells treated with the anti-tumor antibody 14F7
An investigation of the effect of humanized 14F7 on HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC) in combination with LC-MS and microscopy.
ORGANISM(S):
Homo sapiens (Human)
2022-08-08
|
PXD024320
|
Pride
Cancer
Neugc gm3
Silac
Anti-tumor antibody
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
